Ocular Therapeutix Inc. (OCUL) |
|
4.705 0.115 (2.51%)
|
02-28 16:00 |
|
Open: |
4.47 |
Pre. Close: |
4.59 |
|
High:
|
4.779 |
Low:
|
4.4345 |
|
Volume:
|
588,075 |
Market Cap:
|
226M |
|
|
|
|
Ocular Therapeutix Inc is a biopharmaceutical company. It is engaged in developing and commercializing therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.791 - 4.823 |
4.823 - 4.852 |
|
Low:
|
4.355 - 4.394 |
4.394 - 4.429 |
|
Close:
|
4.638 - 4.701 |
4.701 - 4.758 |
|
Technical analysis |
as of: 2020-02-28 4:31:07 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 6.08 One year: 6.80 |
| Support: |
Support1: 4.22 Support2: 3.51 |
| Resistance: |
Resistance1: 5.21 Resistance2: 5.82 |
| Pivot: |
5.18  |
| Moving Average: |
MA(5): 4.88 MA(20): 5.04 
MA(100): 4.01 MA(250): 4.05 |
| MACD: |
MACD(12,26): 0.09 Signal(9): 0.18 |
| Stochastic oscillator: |
%K(14,3): 15.27 %D(3): 25.99 |
| RSI: |
RSI(14): 45.24 |
| 52-week: |
High: 5.82 Low: 2.35 Change(%): -0.1 |
| Average Vol(K): |
3-Month: 62160 10-Days: 54043 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.OCUL has closed above bottom band by 5.9%. Bollinger Bands are 2.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2020-02-13
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (NASDAQ: AGRX ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Allergan plc (NYSE: AGN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Aptose Biosciences Inc (NASDAQ: APTO ) AtriCure Inc. (NASDAQ: ATRC ) AVITA MED LTD/S ADR (NASDAQ: RCEL ) Avrobio Inc (NASDAQ: AVRO ) Beam Therapeutics Inc (NASDAQ: BEAM ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) ChemoCentryx Inc (NASDAQ: CCXI ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fate Therapeutics Inc (NASDAQ: FATE ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) NeoGenomics, Inc. (NASDAQ: NEO ) Novartis AG (NYSE: NVS ) Ocular Therapeutix Inc (NASDAQ: OCUL ) PAVmed Inc (NASDAQ: PAVM ) Penumbra Inc (NYSE: PEN ) Prevail Therapeutics Inc (NASDAQ: PRVL )(reacted to the FDA according Orphan Drug Designation to its experimental gene therapy PR001 for treating Gaucher disease) PTC Therapeutics, Inc (NASDAQ: PTCT ) Repligen Corporation (NASDAQ: RGEN ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) West Pharmaceutical Services Inc.
2019-11-26
Ocular Therapeutix™ to Present at the Piper Jaffray 31st Annual Healthcare Conference
Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix, will present and host
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Global Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
48.08 |
| Shares Float (M) |
40.20 |
|
% Held by Insiders
|
10.98 |
|
% Held by Institutions
|
55.62 |
|
Shares Short (K)
|
6500 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-1.790 |
|
Book Value (p.s.)
|
0.230 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-3300.36 |
|
Return on Assets (ttm)
|
-64.2 |
|
Return on Equity (ttm)
|
-273.7 |
|
Qtrly Rev. Growth
|
66.5 |
|
Gross Profit (p.s.)
|
-0.736 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-1.648 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-71.76 |
|
Levered Free Cash Flow (M)
|
-45.08 |
Stock Valuations |
|
P/E
|
-2.63 |
|
P/E Growth Ratio
|
0.03 |
|
P/BV
|
20.46 |
|
P/S
|
78.41 |
|
P/CF
|
-3.15 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
